Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating bevacizumab (Avastin) with XELOX or FOLFOX-4 chemotherapy in metastatic colorectal cancer; the study has completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Avastin (bevacizumab)
• Capecitabine (capecitabine)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2010-02-26